Skip to main content

SOD enzymes and their mimics in cancer: pro vs anti-odixative mode of action-part II.

Publication ,  Journal Article
Batinić-Haberle, I
Published in: Anticancer Agents Med Chem
May 1, 2011

Duke Scholars

Published In

Anticancer Agents Med Chem

DOI

EISSN

1875-5992

Publication Date

May 1, 2011

Volume

11

Issue

4

Start / End Page

327 / 328

Location

Netherlands

Related Subject Headings

  • Superoxide Dismutase
  • Oxidation-Reduction
  • Neoplasms
  • Medicinal & Biomolecular Chemistry
  • Humans
  • Biomimetic Materials
  • Antioxidants
  • Animals
  • 3404 Medicinal and biomolecular chemistry
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Batinić-Haberle, I. (2011). SOD enzymes and their mimics in cancer: pro vs anti-odixative mode of action-part II. Anticancer Agents Med Chem, 11(4), 327–328. https://doi.org/10.2174/187152011795677508
Batinić-Haberle, Ines. “SOD enzymes and their mimics in cancer: pro vs anti-odixative mode of action-part II.Anticancer Agents Med Chem 11, no. 4 (May 1, 2011): 327–28. https://doi.org/10.2174/187152011795677508.
Batinić-Haberle I. SOD enzymes and their mimics in cancer: pro vs anti-odixative mode of action-part II. Anticancer Agents Med Chem. 2011 May 1;11(4):327–8.
Batinić-Haberle, Ines. “SOD enzymes and their mimics in cancer: pro vs anti-odixative mode of action-part II.Anticancer Agents Med Chem, vol. 11, no. 4, May 2011, pp. 327–28. Pubmed, doi:10.2174/187152011795677508.
Batinić-Haberle I. SOD enzymes and their mimics in cancer: pro vs anti-odixative mode of action-part II. Anticancer Agents Med Chem. 2011 May 1;11(4):327–328.

Published In

Anticancer Agents Med Chem

DOI

EISSN

1875-5992

Publication Date

May 1, 2011

Volume

11

Issue

4

Start / End Page

327 / 328

Location

Netherlands

Related Subject Headings

  • Superoxide Dismutase
  • Oxidation-Reduction
  • Neoplasms
  • Medicinal & Biomolecular Chemistry
  • Humans
  • Biomimetic Materials
  • Antioxidants
  • Animals
  • 3404 Medicinal and biomolecular chemistry
  • 3211 Oncology and carcinogenesis